In clinical trials, donanemab (Kisunla) modestly slowed the pace of thinking declines among patients in the early stages of the memory-robbing disease. But it also carried significant safety risks, including...
4.0 percent of seniors had received dementia diagnosis in 2022
Jun 13, 2024
An increase in the percentage with a dementia diagnosis was seen with increasing age; a decrease was seen with an increasing education level.
The 5-Cog paradigm improves diagnosis, management of dementia
Jun 11, 2024
A threefold improvement was seen in dementia care actions with the 5-Cog paradigm, a culturally adept cognitive detection tool.
Preeclampsia linked to increased risk for young-onset dementia
May 31, 2024
An even higher risk for young-onset dementia was seen for preeclampsia before 34 weeks of gestation or superimposed on chronic hypertension.
High risk for psychiatric disorders seen before dementia diagnosis
Oct 20, 2023
The findings were consistent regardless of dementia subtype.
Housing instability tied to higher risk for dementia diagnosis
Dec 06, 2023
The findings show a 40% higher risk among housing-insecure veterans.
New opioid Rx common, harmful in older adults with dementia
Jul 25, 2023
A new prescription was tied to an 11-fold higher mortality in the first 14 days versus no opioid use.
Dementia incidence increased with termination of metformin
Oct 27, 2023
The association was largely independent of changes in hemoglobin A1c and insulin usage.
Patients with dementia less likely to receive intensive care after hospital transfer
Jan 04, 2024
The authors say that future work should focus on determining whether transfers are needed.
Composite inflammatory biomarker linked to dementia risk
Jul 21, 2023
Small but significant associations were seen between elevated biomarker levels and worsened cognitive performance.